222 related articles for article (PubMed ID: 30868608)
1. Urea in cancer patients with chronic SIAD-induced hyponatremia: Old drug, new evidence.
Nervo A; D'Angelo V; Rosso D; Castellana E; Cattel F; Arvat E; Grossi E
Clin Endocrinol (Oxf); 2019 Jun; 90(6):842-848. PubMed ID: 30868608
[TBL] [Abstract][Full Text] [Related]
2. Oral urea for the treatment of chronic syndrome of inappropriate antidiuresis in children.
Huang EA; Feldman BJ; Schwartz ID; Geller DH; Rosenthal SM; Gitelman SE
J Pediatr; 2006 Jan; 148(1):128-31. PubMed ID: 16423613
[TBL] [Abstract][Full Text] [Related]
3. A Randomized Trial of Empagliflozin to Increase Plasma Sodium Levels in Patients with the Syndrome of Inappropriate Antidiuresis.
Refardt J; Imber C; Sailer CO; Jeanloz N; Potasso L; Kutz A; Widmer A; Urwyler SA; Ebrahimi F; Vogt DR; Winzeler B; Christ-Crain M
J Am Soc Nephrol; 2020 Mar; 31(3):615-624. PubMed ID: 32019783
[TBL] [Abstract][Full Text] [Related]
4. Clinical Experience of the Efficacy and Safety of Low-dose Tolvaptan Therapy in a UK Tertiary Oncology Setting.
Chatzimavridou-Grigoriadou V; Al-Othman S; Brabant G; Kyriacou A; King J; Blackhall F; Trainer PJ; Higham CE
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4766-e4775. PubMed ID: 33693944
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy of empagliflozin as an add-on treatment for chronic SIAD: a case report and literature review.
Bioletto F; Varaldo E; Prencipe N; Benso A; Berton AM
Hormones (Athens); 2023 Jun; 22(2):343-347. PubMed ID: 36656532
[TBL] [Abstract][Full Text] [Related]
6. Case report: Twice-daily tolvaptan dosing regimen in a challenging case of hyponatremia due to SIAD.
Arecco A; Demontis D; Della Sala L; Musso N; Gay S; Boschetti M; Ferone D; Gatto F
Front Endocrinol (Lausanne); 2023; 14():1309657. PubMed ID: 38288467
[TBL] [Abstract][Full Text] [Related]
7. Hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. Rapid correction with urea, sodium chloride, and water restriction therapy.
Decaux G; Unger J; Brimioulle S; Mockel J
JAMA; 1982 Jan 22-29; 247(4):471-4. PubMed ID: 7054549
[TBL] [Abstract][Full Text] [Related]
8. Tolvaptan in the Management of Acute Euvolemic Hyponatremia After Transsphenoidal Surgery: A Retrospective Single-Center Analysis.
Indirli R; Ferreira de Carvalho J; Cremaschi A; Mantovani B; Sala E; Serban AL; Locatelli M; Bertani G; Carosi G; Fiore G; Tariciotti L; Arosio M; Mantovani G; Ferrante E
Front Endocrinol (Lausanne); 2021; 12():689887. PubMed ID: 34108941
[TBL] [Abstract][Full Text] [Related]
9. Euvolemic Hyponatremia Secondary to the Syndrome of Inappropriate Antidiuresis.
Verbalis JG
Front Horm Res; 2019; 52():61-79. PubMed ID: 32097906
[TBL] [Abstract][Full Text] [Related]
10. Fluid Restriction Therapy for Chronic SIAD; Results of a Prospective Randomized Controlled Trial.
Garrahy A; Galloway I; Hannon AM; Dineen R; O'Kelly P; Tormey WP; O'Reilly MW; Williams DJ; Sherlock M; Thompson CJ
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32879954
[TBL] [Abstract][Full Text] [Related]
11. Effect of hyponatremia normalization on osteoblast function in patients with SIAD.
Potasso L; Refardt J; Meier C; Christ-Crain M
Eur J Endocrinol; 2021 Nov; 186(1):1-8. PubMed ID: 34678762
[TBL] [Abstract][Full Text] [Related]
12. Administration of intravenous urea and normal saline for the treatment of hyponatremia in neurosurgical patients.
Reeder RF; Harbaugh RE
J Neurosurg; 1989 Feb; 70(2):201-6. PubMed ID: 2913218
[TBL] [Abstract][Full Text] [Related]
13. Syndrome of Inappropriate Antidiuresis.
Moritz ML
Pediatr Clin North Am; 2019 Feb; 66(1):209-226. PubMed ID: 30454744
[TBL] [Abstract][Full Text] [Related]
14. Vaptans are not the mainstay of treatment in hyponatremia: perhaps not yet.
Gross PA; Wagner A; Decaux G
Kidney Int; 2011 Sep; 80(6):594-600. PubMed ID: 21451459
[TBL] [Abstract][Full Text] [Related]
15. Urea for management of the syndrome of inappropriate secretion of ADH: A systematic review.
de Solà-Morales O; Riera M
Endocrinol Nutr; 2014 Nov; 61(9):486-92. PubMed ID: 24954885
[TBL] [Abstract][Full Text] [Related]
16. Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985.
Decaux G
J Lab Clin Med; 2001 Jul; 138(1):18-21. PubMed ID: 11433224
[TBL] [Abstract][Full Text] [Related]
17. Hyponatremia following mild/moderate subarachnoid hemorrhage is due to SIAD and glucocorticoid deficiency and not cerebral salt wasting.
Hannon MJ; Behan LA; O'Brien MM; Tormey W; Ball SG; Javadpour M; Sherlock M; Thompson CJ
J Clin Endocrinol Metab; 2014 Jan; 99(1):291-8. PubMed ID: 24248182
[TBL] [Abstract][Full Text] [Related]
18. [The syndrome of inappropriate antidiuresis].
Frouget T
Rev Med Interne; 2012 Oct; 33(10):556-66. PubMed ID: 22884285
[TBL] [Abstract][Full Text] [Related]
19. Inappropriate antidiuretic hormone secretion: long-term successful urea treatment.
Chehade H; Rosato L; Girardin E; Cachat F
Acta Paediatr; 2012 Jan; 101(1):e39-42. PubMed ID: 21672011
[TBL] [Abstract][Full Text] [Related]
20. Continuous Versus Bolus Infusion of Hypertonic Saline in the Treatment of Symptomatic Hyponatremia Caused by SIAD.
Garrahy A; Dineen R; Hannon AM; Cuesta M; Tormey W; Sherlock M; Thompson CJ
J Clin Endocrinol Metab; 2019 Sep; 104(9):3595-3602. PubMed ID: 30882872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
